These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 15572480)

  • 1. First-trimester nasal bone evaluation for aneuploidy in the general population.
    Malone FD; Ball RH; Nyberg DA; Comstock CH; Saade G; Berkowitz RL; Dugoff L; Craigo SD; Carr SR; Wolfe HM; Tripp T; D'Alton ME;
    Obstet Gynecol; 2004 Dec; 104(6):1222-8. PubMed ID: 15572480
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interest of foetal nasal bone measurement at first trimester trisomy 21 screening.
    Weingertner AS; Kohler M; Firtion C; Vayssière C; Favre R
    Fetal Diagn Ther; 2006; 21(5):433-8. PubMed ID: 16912493
    [TBL] [Abstract][Full Text] [Related]  

  • 3. First-trimester assessment of nasal bone using retronasal triangle view: a prospective study.
    Adiego B; Martinez-Ten P; Illescas T; Bermejo C; Sepulveda W
    Ultrasound Obstet Gynecol; 2014 Mar; 43(3):272-6. PubMed ID: 23733531
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nuchal translucency and nasal bone in first-trimester ultrasound screening for aneuploidy in multiple pregnancies.
    Sepulveda W; Wong AE; Casasbuenas A
    Ultrasound Obstet Gynecol; 2009 Feb; 33(2):152-6. PubMed ID: 18985621
    [TBL] [Abstract][Full Text] [Related]  

  • 5. First-trimester nuchal translucency, nasal bones, and trisomy 21 in selected and unselected populations.
    Prefumo F; Sairam S; Bhide A; Thilaganathan B
    Am J Obstet Gynecol; 2006 Mar; 194(3):828-33. PubMed ID: 16522420
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Absence of fetal nasal bone and aneuploidies at first-trimester nuchal translucency screening in unselected pregnancies.
    Zoppi MA; Ibba RM; Axiana C; Floris M; Manca F; Monni G
    Prenat Diagn; 2003 Jun; 23(6):496-500. PubMed ID: 12813765
    [TBL] [Abstract][Full Text] [Related]  

  • 7. First-trimester ultrasonographic screening for trisomy 21 using fetal nuchal translucency and nasal bone.
    Sepulveda W; Wong AE; Dezerega V
    Obstet Gynecol; 2007 May; 109(5):1040-5. PubMed ID: 17470580
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Maternal serum biochemistry at 11-13(+6) weeks in relation to the presence or absence of the fetal nasal bone on ultrasonography in chromosomally abnormal fetuses: an updated analysis of integrated ultrasound and biochemical screening.
    Cicero S; Spencer K; Avgidou K; Faiola S; Nicolaides KH
    Prenat Diagn; 2005 Nov; 25(11):977-83. PubMed ID: 16245371
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Additional performance of nasal bone in first trimester screening.
    Kozlowski P; Knippel AJ; Froehlich S; Stressig R
    Ultraschall Med; 2006 Aug; 27(4):336-9. PubMed ID: 16596511
    [TBL] [Abstract][Full Text] [Related]  

  • 10. First-trimester screening for trisomy-21 using a simplified method to assess the presence or absence of the fetal nasal bone.
    Orlandi F; Rossi C; Orlandi E; Jakil MC; Hallahan TW; Macri VJ; Krantz DA
    Am J Obstet Gynecol; 2005 Apr; 192(4):1107-11. PubMed ID: 15846188
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Integrated ultrasound and biochemical screening for trisomy 21 using fetal nuchal translucency, absent fetal nasal bone, free beta-hCG and PAPP-A at 11 to 14 weeks.
    Cicero S; Bindra R; Rembouskos G; Spencer K; Nicolaides KH
    Prenat Diagn; 2003 Apr; 23(4):306-10. PubMed ID: 12673635
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fetal nasal bone assessment in first trimester down syndrome screening.
    Has R; Kalelioglu I; Yuksel A; Ibrahimoglu L; Ermis H; Yildirim A
    Fetal Diagn Ther; 2008; 24(1):61-6. PubMed ID: 18504384
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nasal bone in first-trimester screening for trisomy 21.
    Cicero S; Avgidou K; Rembouskos G; Kagan KO; Nicolaides KH
    Am J Obstet Gynecol; 2006 Jul; 195(1):109-14. PubMed ID: 16813749
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nuchal fold thickness, nasal bone absence or hypoplasia, ductus venosus reversed flow and tricuspid valve regurgitation in screening for trisomies 21, 18 and 13 in the early second trimester.
    Geipel A; Willruth A; Vieten J; Gembruch U; Berg C
    Ultrasound Obstet Gynecol; 2010 May; 35(5):535-9. PubMed ID: 20183867
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of the efficiency of second-trimester nasal bone hypoplasia and increased nuchal fold in Down syndrome screening.
    Odibo AO; Sehdev HM; Gerkowicz S; Stamilio DM; Macones GA
    Am J Obstet Gynecol; 2008 Sep; 199(3):281.e1-5. PubMed ID: 18771983
    [TBL] [Abstract][Full Text] [Related]  

  • 16. First- and second-trimester screening: detection of aneuploidies other than Down syndrome.
    Breathnach FM; Malone FD; Lambert-Messerlian G; Cuckle HS; Porter TF; Nyberg DA; Comstock CH; Saade GR; Berkowitz RL; Klugman S; Dugoff L; Craigo SD; Timor-Tritsch IE; Carr SR; Wolfe HM; Tripp T; Bianchi DW; D'Alton ME;
    Obstet Gynecol; 2007 Sep; 110(3):651-7. PubMed ID: 17766613
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nuchal translucency and nasal bone for trisomy 21 screening: single center experience.
    Monni G; Zoppi MA; Ibba RM; Floris M; Manca F; Axiana C
    Croat Med J; 2005 Oct; 46(5):786-91. PubMed ID: 16158472
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The association between fetal nasal bone hypoplasia and aneuploidy.
    Odibo AO; Sehdev HM; Dunn L; McDonald R; Macones GA
    Obstet Gynecol; 2004 Dec; 104(6):1229-33. PubMed ID: 15572481
    [TBL] [Abstract][Full Text] [Related]  

  • 19. First and second trimester evaluation of risk for fetal aneuploidy: the secondary outcomes of the FASTER Trial.
    D'Alton M; Cleary-Goldman J
    Semin Perinatol; 2005 Aug; 29(4):240-6. PubMed ID: 16104675
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of the gap between the fetal nasal bones at 11 to 13 + 6 weeks of gestation by three-dimensional ultrasound.
    Peralta CF; Falcon O; Wegrzyn P; Faro C; Nicolaides KH
    Ultrasound Obstet Gynecol; 2005 May; 25(5):464-7. PubMed ID: 15816008
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.